Table 3.
Preoperative prognostic factors for 1‐year mortality after RARC according to univariate COX regression
| Variables | HR | 95%CI | P value |
|---|---|---|---|
| Age (>60 vs ≤60) | 8.37 | 2.00‐35.08 | 0.004 |
| Gender (male vs female) | 0.959 | 0.368‐2.496 | 0.931 |
| BMI (≥22.6 vs <22.6) | 0.542 | 0.267‐1.099 | 0.089 |
| ASA score (≥3 vs <3) | 1.526 | 0.626‐3.720 | 0.353 |
| No. of tumors (multiple vs solitary) | 0.599 | 0.287‐1.251 | 0.173 |
| Clinical stage (vs. ≤T1) | |||
| T2 | 3.264 | 0.763‐13.966 | 0.111 |
| ≥T3 | 9.217 | 1.990‐42.690 | 0.005 |
| Pathological type (NUC vs UC) | 0.568 | 0.077‐4.163 | 0.578 |
| Pathological grade (HGPUC vs LGPUC) | 1.372 | 0.587‐3.207 | 0.465 |
| Hydronephrosis (present vs absent) | 1.714 | 1.086‐2.706 | 0.021 |
| Fibrinogen (high vs low) | 2.787 | 1.326‐5.858 | 0.007 |
| NLR (high vs low) | 25.360 | 0.308‐2088.523 | 0.151 |
| PLR (high vs low) | 2.876 | 1.104‐7.490 | 0.031 |
| LMR (high vs low) | 1.363 | 0.325‐5.711 | 0.672 |
| AGR (high vs low) | 0.674 | 0.205‐2.218 | 0.517 |
| PNI (low vs high) | 3.002 | 1.231‐7.318 | 0.016 |
Abbreviations: AGR, albumin‐globulin ratio; ASA, American Society of Anesthesiologists; BMI, body mass index; HGPUC, high‐grade papillary urothelial carcinoma; IQR, interquartile range; LGPUC, low‐grade papillary urothelial carcinoma; LMR, lymphocyte‐monocyte ratio; NLR, neutrophil‐lymphocyte ratio; NUC, non‐urothelial carcinoma; PLR, platelet‐lymphocyte ratio; PNI, prognostic nutritional index; PUNLMP, papillary urothelial neoplasm of low malignant potential; UC, urothelial carcinoma.